Want to see HK:2228 full AI Analyst Report?
QuantumPharm, Inc. (2228) Financial Statements
QuantumPharm, Inc. Financial Overview
QuantumPharm, Inc.'s market cap is currently $26.26B. The company's EPS TTM is $-0.05; its P/E ratio is -100.55; and it has a dividend yield of 3.17%. QuantumPharm, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 781.85M | $ 266.43M | $ 174.42M | $ 133.35M | $ 62.80M |
| Gross Profit | $ 544.71M | $ 123.43M | $ 48.24M | $ 66.09M | $ 32.78M |
| Operating Income | $ -496.50M | $ -684.21M | $ -722.31M | $ -525.31M | $ -299.43M |
| EBITDA | $ 253.59M | $ -575.30M | $ -1.78B | $ -1.38B | $ -2.11B |
| Net Income | $ 120.54M | $ -1.52B | $ -1.91B | $ -1.44B | $ -2.14B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.07B | $ 3.10B | $ 2.83B | $ 3.47B | $ 3.83B |
| Total Assets | $ 10.22B | $ 4.35B | $ 4.01B | $ 4.32B | $ 4.38B |
| Total Debt | $ 443.46M | $ 148.76M | $ 11.04B | $ 9.45B | $ 7.83B |
| Net Debt | $ -2.15B | $ -1.02B | $ 10.33B | $ 8.88B | $ 4.31B |
| Total Liabilities | $ 786.95M | $ 362.43M | $ 11.25B | $ 9.63B | $ 7.99B |
| Stockholders' Equity | $ 9.39B | $ 3.96B | $ -7.27B | $ -5.33B | $ -3.61B |
| Cash Flow | |||||
| Free Cash Flow | $ -199.96M | $ -536.79M | $ -698.20M | $ -627.83M | $ -417.42M |
| Operating Cash Flow | $ -139.62M | $ -478.68M | $ -567.56M | $ -429.10M | $ -253.75M |
| Investing Cash Flow | $ -3.87B | $ 74.09M | $ 735.58M | $ -2.76B | $ -70.47M |
| Financing Cash Flow | $ 5.43B | $ 840.00M | $ -25.89M | $ 57.99M | $ 2.48B |
Currency in CNY
